Desk note · industry · Hospitals / healthcare
Medanta’s September-quarter revenue rose a third as its Noida hospital broke even on EBITDA
Global Health Ltd, which runs the Medanta hospital chain, said on 3 November 2026 that consolidated revenue grew about 33.6% year on year in the September quarter while operating EBITDA margin expanded to about 25.2%, with management highlighting strong patient volumes, higher occupancy, and EBITDA breakeven at its Noida cluster.

- •Consolidated revenue rose about 33.6% year on year in Q2 FY27 while operating EBITDA increased about 60.2%, with EBITDA margin at about 25.2% versus a year earlier.
- •Profit after tax attributable to owners grew about 38.3% in the quarter; management cited volume growth, higher occupancy, and gains in Cluster 2 markets.
- •The Noida facility reached EBITDA breakeven in the period, a milestone for a newer cluster that had been absorbing start-up costs.
What's going on here?
Global Health Ltd, listed as Medanta, published September-quarter results on 3 November 2026 showing consolidated revenue growth of about 33.6% year on year. Operating EBITDA rose about 60.2%, pushing EBITDA margin to about 25.2%. Profit after tax attributable to owners increased about 38.3%. In its update, the company pointed to strong patient volumes, better occupancy, and performance in its Cluster 2 geographies. It also said its Noida hospital cluster reached EBITDA breakeven during the quarter, meaning operating earnings at that site covered operating costs after earlier ramp-up losses.
What does this mean?
Private hospitals earn when beds fill and when payers accept tariff revisions on procedures and room categories. A one-third revenue jump with a wider EBITDA margin suggests both footfall and mix moved in Medanta’s favour, not a single one-off surgery line. Breakeven at Noida matters because new campuses depress group margins for years; crossing that line frees capital for the next specialty tower rather than endless subsidies from mature Gurugram units. For urban middle-class patients, sustained occupancy at branded chains is one signal that elective procedures, maternity packages, and planned surgeries are still being booked despite higher EMI burdens elsewhere in the household budget.
Why should I care?
If you are comparing health insurance or corporate tie-ups, occupancy and margin trends at large chains hint at whether networks can absorb more cashless volume without cutting corners. Employers renewing group mediclaim should watch whether hospital groups expand bed counts faster than admission growth. Investors in listed hospital names should read cluster-wise EBITDA disclosures and capex on new brownfield wings rather than day-one share reactions. Watch Medanta’s occupancy metrics on the next call, progress at other newer clusters, and whether tariff hikes stick after regulatory scrutiny on billing.
More desk notes
Markets / GIFT IFSC
GIFT Nifty open interest set a fresh record above $22 billion
NSE International Exchange said on 19 November 2026 that GIFT Nifty open interest reached $22.21 billion on 18 November, topping the prior October peak as offshore index contracts keep drawing hedging and speculative flow at GIFT City.
Financial services / broking
Fairfax now owns more than half of IIFL Capital Services
FIH Mauritius Investments bought an 11.8% block from promoters on 19 November 2026 for about ₹1,540 crore, lifting the Fairfax group's combined holding in IIFL Capital Services Ltd past 50% as it funds the IDBI Bank takeover.
Power transmission
Adani Energy won a Bihar link for a 2,400 megawatt power plant
Adani Energy Solutions Ltd secured a tariff-based transmission project on 19 November 2026 to evacuate power from the 2,400 MW Pirpainti thermal plant in Bihar, adding 881 circuit kilometres and about ₹500 crore of annual regulated revenue when the lines go live by late 2028.
Consumer durables / travel goods
VIP Industries is pushing premium luggage after two growth quarters
Managing director Atul Jain said on 19 November 2026 that VIP Industries grew consolidated revenue 15% in the September quarter, narrowed losses, and leaned on premium SKUs, roughly 65 new ranges, and wider retail reach while passing three price hikes totalling 7–8% in six months.
For informational purposes only. Not investment advice. Verify with filings and a licensed adviser.